TY  - JOUR

T1  - Canakinumab for atherosclerotic disease

JO  - The New England Journal of Medicine

UR  - https://eprints.whiterose.ac.uk/id/eprint/126384

UR  - https://doi.org/10.1056/NEJMc1714635

PY  - 2018/01/11

AU  - Rothman AM

AU  - Morton A

AU  - Crossman D

ED  - 

DO  - DOI: 10.1056/NEJMc1714635

PB  - Massachusetts Medical Society

VL  - 378

SP  - 196

EP  - 200

Y2  - 2025/11/21

ER  -